Unpacking overuse of androgen deprivation therapy for prostate cancer to inform de-implementation strategies

Unpacking overuse of androgen deprivation therapy for prostate cancer to inform de-implementation strategies

Abstract Background Many men with prostate cancer will be exposed to androgen deprivation therapy (ADT). While evidence-based ADT use is common, ADT is also used in cases with no or limited evidence resulting in more harm than benefit, i.e., overuse. Since there are risks of ADT (e.g., diabetes, ost...

Full description

Bibliographic Details
Main Authors: Ted A. Skolarus, Sarah T. Hawley, Jane Forman, Anne E. Sales, Jordan B. Sparks, Tabitha Metreger, Jennifer Burns, Megan V. Caram, Archana Radhakrishnan, Lesly A. Dossett, Danil V. Makarov, John T. Leppert, Jeremy B. Shelton, Kristian D. Stensland, Jennifer Dunsmore, Steven Maclennan, Sameer Saini, Brent K. Hollenbeck, Vahakn Shahinian, Daniela A. Wittmann, Varad Deolankar, S. Sriram
Format: Article
Language:English
Published: BMC 2024-04-01
Series:Implementation Science Communications
Subjects:
Implementation
Behavior change
De-implementation
Low-value
Intervention
Behavioral theory
Online Access:https://doi.org/10.1186/s43058-024-00576-x

Internet

https://doi.org/10.1186/s43058-024-00576-x

Similar Items